Skip to content

Supplemental Oxygen in Colorectal Surgery: A Quality Improvement Project

Supplemental Oxygen and Surgical-site Infections: An Alternating Intervention Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01777568
Enrollment
5749
Registered
2013-01-29
Start date
2012-11-30
Completion date
2016-11-30
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

30% Oxygen Concentration During Colorectal Surgery, 80% Oxygen Concentration During Colorectal Surgery

Brief summary

Our primary objective is to develop a clinical pathway for care of patients having colorectal surgery at the Clinic. In particular, the investigators would like to determine what intraoperative concentration of oxygen is optimal in our patients.

Detailed description

The investigators therefore propose to test the primary hypothesis that supplemental oxygen (80% versus 30%) reduces the risk of a composite of surgical sites infection and potentially oxygen-related wound complications. Secondarily, the investigators will assess the incremental cost benefit of 80% versus 30% oxygen. As a safety measure, enough oxygen will always be given to maintain oxygen saturation (as determined by pulse oximetry) ≥95%.

Interventions

Inspired oxygen will be maintained at 30%.

Inspired oxygen will be maintained at 30%.

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

The designated operating-room suite alternated between using either 30% oxygen as tolerated or 80% oxygen for periods of 2 weeks. For example, the first period used 30% oxygen, the second 80% oxygen, and so on. The oxygen concentration during the initial period was randomly designated by the study statistician. But, thereafter, oxygen delivery was not randomized on a per-patient or even per-period basis.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adult colorectal surgical patients

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With One or More Composite ComplicationsPostoperative 30 daysA composite of complications: 1. surgical sites infection (organ space / deep) 2. Anastomotic leak 3. Intra-abdominal abscess 4. Sepsis 5. Wound dehiscence 6. Death

Secondary

MeasureTime frameDescription
Number of Participants With Superficial SSI (Surgical Site Infection)Postoperative 30 dayssuperficial SSI (Surgical Site Infection)

Countries

United States

Participant flow

Participants by arm

ArmCount
30% Oxygen
Inspired oxygen will be maintained at 30%. 30% oxygen: Inspired oxygen will be maintained at 30%.
2,853
80% Oxygen
Inspired oxygen will be maintained at 80%. 80% oxygen: Inspired oxygen will be maintained at 30%.
2,896
Total5,749

Baseline characteristics

Characteristic30% Oxygen80% OxygenTotal
Age, Continuous52 years
STANDARD_DEVIATION 17
52 years
STANDARD_DEVIATION 17
52 years
STANDARD_DEVIATION 17
Race/Ethnicity, Customized
Africa American
235 Participants207 Participants442 Participants
Race/Ethnicity, Customized
Caucasian
2558 Participants2627 Participants5185 Participants
Race/Ethnicity, Customized
other
60 Participants62 Participants122 Participants
Sex: Female, Male
Female
1358 Participants1387 Participants2745 Participants
Sex: Female, Male
Male
1495 Participants1509 Participants3004 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
10 / 2,85320 / 2,896
other
Total, other adverse events
183 / 2,853150 / 2,896
serious
Total, serious adverse events
314 / 2,853314 / 2,896

Outcome results

Primary

Number of Participants With One or More Composite Complications

A composite of complications: 1. surgical sites infection (organ space / deep) 2. Anastomotic leak 3. Intra-abdominal abscess 4. Sepsis 5. Wound dehiscence 6. Death

Time frame: Postoperative 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
30% OxygenNumber of Participants With One or More Composite Complications314 Participants
80% OxygenNumber of Participants With One or More Composite Complications314 Participants
p-value: 0.8595% CI: [0.85, 1.14]GEE model
Secondary

Number of Participants With Superficial SSI (Surgical Site Infection)

superficial SSI (Surgical Site Infection)

Time frame: Postoperative 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
30% OxygenNumber of Participants With Superficial SSI (Surgical Site Infection)183 Participants
80% OxygenNumber of Participants With Superficial SSI (Surgical Site Infection)150 Participants
p-value: 0.04795% CI: [0.66, 1.01]Chi-squared

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026